StockData
HealthEquity, Inc. logo

HealthEquity, Inc. (HQY) stock analysis

HQYNasdaqServices-Business Services, NECFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Aug 27, 2026Score 15/305% below fair value
$101.84−2.74 (-2.62%)

Close on Nov 17, 2026Market cap $8.42BP/E 36.8Yield –

StockData Score

Prices as of Nov 16, 2026How the score works

Value3Growth3Performance4Health5Dividend0

Solid15 of 30 checks passed

HealthEquity passes 15 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
3/6
Growth
3/6
Past performance
4/6
Financial health
5/6
Dividend
0/6

What stands out

  • Trading below fair value

    The share price of $104.58 is below our fair value estimate of $110.35.

  • Earnings grew over 5 years

    Net income grew 89.4% a year on average over the last five fiscal years.

  • Revenue growing 10%+ a year

    Revenue grew 15.1% a year over the last three fiscal years.

  • Interest well covered

    Operating income covers interest expense 6.7 times.

What to watch

  • Margin of safety under 20%

    The price is 5.2% below fair value, less than the 20% cushion we look for.

  • Return on equity under 15%

    Return on equity was 11.4% over the last twelve months and averaged 2.7% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 9.8%, below the 10% that usually covers the cost of capital.

  • High debt

    Debt is 46.8% of shareholders' equity, above the 40% we consider low.

Valuation3/6
  • P/E below its 5-year median

    HealthEquity's P/E of 37.8 is below its own 5-year median of 76.6.

  • P/E above the industry

    HealthEquity's P/E of 37.8 is above the Miscellaneous Business Services median of 25.6.

  • EV/EBITDA below its 5-year median

    HealthEquity's EV/EBITDA of 18.3 is below its 5-year median of 28.6.

  • P/B above the industry

    HealthEquity's price-to-book of 4.35 is above the Miscellaneous Business Services median of 2.53.

  • Trading below fair value

    The share price of $104.58 is below our fair value estimate of $110.35.

  • Margin of safety under 20%

    The price is 5.2% below fair value, less than the 20% cushion we look for.

Growth3/6
  • Revenue growing 10%+ a year

    Revenue grew 15.1% a year over the last three fiscal years.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings growth not accelerating

    Net income grew 62.2% over the last twelve months, against a 5-year average of 89.4% a year.

  • Growing slower than the industry

    Revenue grew 7.3% over the last twelve months; the Miscellaneous Business Services median is 9.7%.

  • Guidance raised

    HealthEquity raised its fiscal year ending January 31, 2027 revenues outlook on Aug 27, 2026.

  • Gross margin improving

    Gross margin was 71.2% over the last twelve months, against 66.4% a year earlier.

Past performance4/6
  • Return on equity under 15%

    Return on equity was 11.4% over the last twelve months and averaged 2.7% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 9.8%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    HealthEquity's return on equity of 11.4% is above the Miscellaneous Business Services median of 6.3%.

  • Earnings grew over 5 years

    Net income grew 89.4% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 17.4% over the last twelve months, against a 5-year average of 4.2%.

  • Net margin above the industry

    HealthEquity's net margin of 17.4% is above the Miscellaneous Business Services median of 4.6%.

Financial health5/6
  • High debt

    Debt is 46.8% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 71.6% five years ago to 46.8%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 52.6% of total debt.

  • Interest well covered

    Operating income covers interest expense 6.7 times.

  • Short-term assets cover short-term debts

    Current assets are 2.99 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 5.00; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    HealthEquity has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$110.35

The share price is 5% below this estimate.

20%+ below
Near fair value
20%+ above
$104.58Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E45.0×76.6×25.6×$124.6540%
EV/EBITDA22.4×28.6×16.0×$129.4935%
P/B2.9×3.3×2.5×$70.0310%
Earnings power7.7% cost of equity––$54.4715%
Fair value$110.35100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 76.6
  • Miscellaneous Business Services median 25.6

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$78.70M
Value traded per 1% price move
$59.15M

Downside

Medium risk

Typical loss in a bad month
15.2%
Volatility (annualized)
35%
Sharpe ratio, 1 year
0.01
Beta to the S&P 500 (5Y)
0.35

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

69.5%+12.9 pts over 5 years

Operating margin

24.6%+19.9 pts over 5 years

Net margin

16.4%+15.2 pts over 5 years

See a number that looks wrong?